Dublin-based healthcare software firm IMS Maxims has been given court protection from its creditors while it restructures to try and secure its finances, according to market analyst Techmarketview.
The High Court in Dublin appointed an interim examiner to the group last week having been satisfied that it had a reasonable prospect of surviving as a going concern. CEO Shane Tickell said it would be ‘business as usual’ during the court ‘examinership’, which is similar to Chapter 11 bankruptcy in the US.
Techmarketview's Tola Sargeant says that IMS Maxims’ clinical and administrative software is used to store the records of 9.9m people in the UK and Ireland. Its NHS customer base includes Trusts such as Clatterbridge Centre for Oncology, Great Ormond Street Childrens’ Hospital, the National Centre for Spinal Injuries and Guys & St Thomas’ Hospital.
"Allowing the company to go bankrupt would cause considerable disruption for these hospitals and their patients since it wouldn’t be easy for another supplier to step in and support the software," says Sargeant.
It may be too easy to say that the supplier is a potential casualty of the NPfIT though. As Sargeant says, IMS Maxims lacks the scale to be a serious contender in the NHS IT market.
The supplier's existing customers should be too worried. I am told it is highly unlikely the company will go bust.